US2011183924A1PendingUtilityA1
Methods and systems for annotating biomolecular sequences
Est. expirySep 14, 2021(expired)· nominal 20-yr term from priority
Inventors:Liat MintzHanqing XieDvir DaharyErez LevanonShiri FreilichNili BeckWei-Yong ZhuAlon WassermanJeanne Bernstein
A61P 37/00A61P 35/00G16B 20/00A61P 29/00G16B 40/00A61P 31/00G16B 30/00G16B 30/10G16B 30/20G16B 40/30G16B 40/10
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of annotating biomolecular sequences. The method comprises (a) computationally clustering the biomolecular sequences according to a progressive homology range, to thereby generate a plurality of clusters each being of a predetermined homology of the homology range; and (b) assigning at least one ontology to each cluster of the plurality of clusters, the at least one ontology being: (i) derived from an annotation preassociated with at least one biomolecular sequence of each cluster; and/or (ii) generated from analysis of the at least one biomolecular sequence of each cluster thereby annotating biomolecular sequences.
Claims
exact text as granted — not AI-modified1 . An isolated protein having the sequence according to the amino acid sequence of any of SEQ ID NOs: 35-38, 737437-1034311.
2 . An isolated polynucleotide, consisting of a nucleic acid sequence encoding the amino acid sequence of the protein of claim 1 .
3 . A pharmaceutical composition comprising an isolated protein having the sequence according to the amino acid sequence of any of SEQ ID NOs: 35-38, 737437-1034311, and a pharmaceutically acceptable carrier.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.